Open access · CC-BY
via OpenAlex
Evidence for dysbiosis in the gut microbiome of patients with systemic mastocytosis
Lauren E. Krausfeldt, Vivian Cao, Richard Rosario Rodrigues, Wendy A. Henderson, Robin A. Eisch, Linda M. Scott, Dean D. Metcalfe, Hirsh D. Komarow
Journal of Allergy and Clinical Immunology Global · 2025
Abstract
Background: Limited research studies have investigated the role of the gut microbiome in systemic mastocytosis (SM), which is characterized by an aberrant expansion of clonal mast cells in specific tissues including the skin, marrow, liver, and the gastrointestinal tract. Objectives: We sought to investigate the relationship between the intestinal microbiome and clinical manifestations of SM. Methods: The V4 region of the 16S rRNA gene was sequenced from stool samples of 22 patients with SM and 9 healthy controls. Microbial community composition, diversity, and functional genes inferred from 16S rRNA gene sequences were analyzed. ClinicalTrials.gov Identifier NCT00044122. Results: = .04). Predicted functions of the gut microbiome suggested that there were differences in metabolite profiles, including short-chain fatty acids, increased virulence factors, and decreased bacterial defense mechanisms in patients with SM. Dietary components were associated with symptoms, quality of life, and markers of mast cell activation and inflammation, as well as changes in microbial composition and predicted function in patients with SM. Conclusions: Dysbiosis of the gut microbiome is evident in patients with SM and is seemingly associated with mast cell activation. In addition, diet may further alter microbial composition and metabolism in the gut of patients with SM.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jacig.2025.100578
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Krausfeldt, L.E., Cao, V., Rodrigues, R.R., Henderson, W.A., Eisch, R.A., Scott, L.M., Metcalfe, D.D., & Komarow, H.D. (2025). Evidence for dysbiosis in the gut microbiome of patients with systemic mastocytosis. <em>Journal of Allergy and Clinical Immunology Global</em>. https://doi.org/10.1016/j.jacig.2025.100578
Vancouver
Krausfeldt LE, Cao V, Rodrigues RR, Henderson WA, Eisch RA, Scott LM, et al. Evidence for dysbiosis in the gut microbiome of patients with systemic mastocytosis. Journal of Allergy and Clinical Immunology Global. 2025. doi:10.1016/j.jacig.2025.100578.
BibTeX
@article{lauren2025Eviden,
title = {Evidence for dysbiosis in the gut microbiome of patients with systemic mastocytosis},
author = {Lauren E. Krausfeldt and Vivian Cao and Richard Rosario Rodrigues and Wendy A. Henderson and Robin A. Eisch and Linda M. Scott and Dean D. Metcalfe and Hirsh D. Komarow},
journal = {Journal of Allergy and Clinical Immunology Global},
year = {2025},
doi = {10.1016/j.jacig.2025.100578},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Diabetes Research 2018
Open access · CC-BY
Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet
World Journal of Hepatology 2022
Open access · CC-BY
Gut dysbiosis and body composition in cirrhosis
Movement Disorders 2017
Preprint · OA
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome
Annals of the Rheumatic Diseases 2024
Citation only
AB0346 GUT MICROBIOME DYSBIOSIS IN ASIAN PATIENTS WITH KNEE OSTEOARTHRITIS
Nature Communications 2023
Open access · CC-BY
Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia
Alimentary Pharmacology & Therapeutics 2015
Open access · OA